P158 PONDx Aragon: First spanish prospective study evaluating the impact of the 21-gene test on real praxis for N1 patients after RxPONDER results

Autor: Andres, R., Hernandez, A., Fernandez, A., Comin, A., Nuño, A., Aguirre, E., Arevalo, E., Millastre, E., Alvarez, I., Verdun, J.A., Lao, J., Murillo, L., Galan, N., Bueso, P., Puertolas, T., Hagen, C., Inglada-Perez, L., Anton, A.
Zdroj: In The Breast April 2023 68 Supplement:S77-S77
Databáze: ScienceDirect